This is the first time that the mechanism for PGC1β-mediated HKDC1 expression has been discovered in breast cancers, and this provides a new strategy for cancer therapy through targeting the PGC1β/HKDC1 signaling pathway. Here, HKDC1 is linked to breast cancer.